An interventional study of Individually tailored lifestyle feedback and Standard leaflet in Lifestyle, Diet Habit and Smoking Cessation, sponsored by Oslo University Hospital. Completed. Open to participants aged 50 Years to 74 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-28.
Sponsored by Oslo University Hospital · Not applicable, Interventional, and Prevention
This randomized controlled trial aims to investigate the effect of an individually tailored lifestyle feedback letter and a leaflet on lifestyle in the context of sigmoidoscopy screening.
Cancer screening may be used as a teachable moment for healthy lifestyle behaviours. This study aims to investigate the effect of minimal, but individually tailored lifestyle advice and a standard leaflet on healthy lifestyle given at a colorectal cancer screening context on one-year changes in these behaviours in a population-based sample of men and women.
Individuals invited to sigmoidoscopy screening in the piloting of Norwegian Bowel Cancer Screening are additionally invited to this lifestyle intervention study. Changes in lifestyle are measured by a brief lifestyle questionnaire administered at prescreening and after one year. The intervention to the intervention arms is given after completion of the prescreening lifestyle questionnaire.
Exclusion Criteria:
Written, standardized individually tailored lifestyle feedback based on participants responses to a lifestyle questionnaire, and a leaflet on healthy lifestyle mailed to the participant.
Behavioral: Individually tailored lifestyle feedback · Behavioral: Standard leaflet
A leaflet on healthy lifestyle mailed to the participant.
Behavioral: Standard leaflet
No contact with the participant.
The written, standardized individually tailored lifestyle feedback includes feedback on consumption of fruit, berries and vegetables and alcohol, physical activity, smoking and body mass index.
The leaflet is The Norwegian Cancer Society's one-page information brochure on healthy lifestyle behaviours for low cancer risk, including non-smoking, healthy body weight, physical activity, diet, moderate alcohol consumption, moderate sun exposure etc.
A questionnaire-based lifestyle score
A score variable ranging from 0 (least favorable) to 6 (most favorable), calculated as the sum of self-reported favorable lifestyle factors assessed by a questionnaire; non-smoking (1 score point), body mass index less than 25 kg/m2 (1 score point), a minimum of seven physical activity sessions of 30 minutes per a week (1 score point), a maximum of four dinner servings of red and processed meat per a week (1 score point), a minimum of three servings of fruit, berries and vegetables per a day (0.5 score point) and a minimum of one serving of fatty fish per a week (0.5 score points)
Time frame: One year; from pre-screening until one year after
Smoking status
Self-reported smoking status (smoking vs. non-smoking), assessed by a questionnaire
Time frame: One year; from pre-screening until one year after
Alcohol consumption
Self-reported consumption of alcoholic beverages (glasses/week), assessed by a questionnaire
Time frame: One year; from pre-screening until one year after
Physical activity
Self-reported weekly time spent in physical activity (number of 30-minute activity sessions per week), assessed by a questionnaire
Time frame: One year; from pre-screening until one year after
Consumption of fruit and vegetables
Self-reported consumption of fruit, berries and vegetables (servings per day), assessed by a questionnaire
Time frame: One year; from pre-screening until one year after
Body weight
Self-reported body weight (whole kilograms), assessed by a questionnaire
Time frame: One year; from pre-screening until one year after
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oslo University Hospital